E-Learning Platform · Admissions Open +91 91089 56193 WhatsApp Us
Home / Courses

Advanced PG Diploma programs, on our e-learning platform

Six industry-focused, 6-month programs in Clinical Research, Pharmacovigilance, Clinical Data Management, Clinical SAS and Bioinformatics.

All Programs

Choose your path

Mode of Learning

One mode, done properly: E-Learning Platform

Every CliniXen program is delivered fully online — so you can learn from any city, alongside college or work, without compromising on live interaction and mentor support.

Learn from anywhere Flexible timings AI-enabled learning

Online Learning

  • Live interactive virtual sessions
  • Flexible learning from any location
  • Recorded lectures for revision
  • Real-time mentor Q&A support
  • LMS access for assignments and resources
Program Benefits

Everything you need to move into industry

Every component is built with one goal — to guide, support and uplift you at every stage, from your first class to your first job.

Expert Career Guidance
Flexible Learning
Hands-on Projects
Industry Expert Sessions
Mock Interviews
ATS-Friendly Resume
Placement Assistance
Curated Job Opportunities
Cross-skilling by Domain
Collaborative Learning
Revision & Retraining Sessions
Student-centric & Employability-first
Main Features

Main features of the programs

  • Live online classes with industry experts
  • User-friendly online learning platform (LMS)
  • High-quality, industry-aligned course content
  • Recorded sessions — learn 24×7 at your own pace
  • Program addresses USFDA regulations
  • ICH-GCP guidelines & Indian regulations
  • Ethical considerations & practical application
  • Assignments, case studies & projects
  • Placement support

Not sure which course fits you?

Tell us your background and we’ll give you a straight answer — free, no obligation.

Admissions Open

Take The Next Step Now

Here's your chance to be a part of CliniXen's live e-learning programs. Share your details and our admissions counsellor will get in touch with you to explore further.